Expression of matrix macromolecules and functional properties of EGF-responsive colon cancer cells are inhibited by panitumumab. (Q39283868)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22956286%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

title

Expression of matrix macromolecules and functional properties of EGF-responsive colon cancer cells are inhibited by panitumumab (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22956286%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22956286%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Ch Gialeli

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22956286%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

A D Theocharis

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22956286%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

D Kletsas

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22956286%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

G N Tzanakakis

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22956286%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

language of work or name

1 reference

6 September 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22956286%20AND%20SRC:MED&resulttype=core&format=json

Investigational New Drugs

12 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22956286%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22956286%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22956286%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

page(s)

516-524

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22956286%20AND%20SRC:MED&resulttype=core&format=json

Epidermal growth factor receptor signal transactivation

12 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9875-X

Epidermal growth factor receptor signaling in colorectal cancer: preclinical data and therapeutic perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9875-X

The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9875-X

Proteoglycans in health and disease: emerging concepts and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9875-X

Metalloproteinases in health and disease: challenges and the future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9875-X

Syndecan-4 and focal adhesion function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9875-X

Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9875-X

Imatinib inhibits colorectal cancer cell growth and suppresses stromal-induced growth stimulation, MT1-MMP expression and pro-MMP2 activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9875-X

Higher expression of epidermal growth factor receptor is associated with extracellular matrix metalloprotease inducer in colorectal adenocarcinoma: tissue microarray analysis of immunostaining score with clinicopathological parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9875-X

Human breast cancer cell-mediated bone collagen degradation requires plasminogen activation and matrix metalloproteinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9875-X

Panitumumab: human monoclonal antibody against epidermal growth factor receptors for the treatment of metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9875-X

Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9875-X

Targeting epidermal growth factor receptor in solid tumors: critical evaluation of the biological importance of therapeutic monoclonal antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9875-X

In vivo and in vitro antitumor activity of oxaliplatin in combination with cetuximab in human colorectal tumor cell lines expressing different level of EGFR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9875-X

PIK3CA mutation/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9875-X

KRAS mutation in colon cancer: a marker of resistance to EGFR-I therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9875-X

The role of syndecans in disease and wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9875-X

Anti‐EGFR Monoclonal Antibodies for Treatment of Colorectal Cancers: Development of Cetuximab and Panitumumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9875-X

Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9875-X

Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9875-X

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9875-X

Targeting focal adhesion kinase signaling in tumor growth and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9875-X

Epidermal growth factor-induced tumor cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9875-X

Membrane type-matrix metalloproteinases and tumor progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9875-X

Invadopodia: specialized cell structures for cancer invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9875-X

Inhibition of matrix metalloproteinase 14 (MMP-14)-mediated cancer cell migration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9875-X

Epidermal growth factor receptor-dependent and -independent cell-signaling pathways originating from the urokinase receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9875-X

EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9875-X

Inhibition of focal adhesion kinase expression or activity disrupts epidermal growth factor-stimulated signaling promoting the migration of invasive human carcinoma cells

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22956286

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Regulation of extracellular matrix metalloproteinase inducer and matrix metalloproteinase expression by amphiregulin in transformed human breast epithelial cells.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22956286

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Regulatory roles of hyaluronan in health and disease

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22956286

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S10637-012-9875-X

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22956286%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22956286%20AND%20SRC:MED&resulttype=core&format=json